Transcription profiling of human breast tumors resistant or sensitive to docetaxel treatment

ABSTRACT: This SuperSeries is composed of the following subset Series: GSE349: These patients proved resistant to docetaxel treatment, exhibiting residual tumor of 25% or greater remaining volume. Resistant GSE350 These patients were sensitive to docetaxel treatment, exhibiting less than 25% residual tumor.

ORGANISM(S): Homo sapiens

SUBMITTER: Eric Wooten 

PROVIDER: E-GEOD-6434 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress